Destek Sitesi platformunda Uzman olmak ister misiniz?

Uzman olmak için Şimdi başvurun.

Deneysel Kafa Travması Sonrası Gelişen Akciğer Hasarında; Eritropoetin ve Metilprednizolonun Koruyucu Etkisi

Oluşturulma tarihi: 18.02.2025 21:56    Güncellendi: 18.02.2025 21:56
Türk Göğüs Kalp Damar Cerrahisi Dergisi 2006;14(2):122-127



ERKAN YILDIRIM; KANAT ÖZIŞIK; PINAR ÖZIŞIK; MUSTAFA EMİR; ENGİN YILDIRIM; KAMER KILINÇ



Amaç: Sıçanlarda kafa travması sonrası gelişen akciğer hasarında; eritropoetin ve metilprednizolonun akciğer lipid peroksidasyonu ve miyeloperoksidaz seviyesine etkileri araştırıldı. Çalışma planı: Yetmiş altı adet 180-220 gr ağırlığında; dişi Wistar-Albino sıçan 10 gruba ayrıldı. Kafa travması oluşturmak için ağırlık düşürme yöntemi kullanıldı. Örnekler; hasar oluşturulduktan 24 saat sonra sol akciğerden alındı. Akciğer doku miyeloperoksidaz aktivitesi ve lipid peroksidasyon seviyeleri ölçüldü. Lipid peroksidasyon seviyelerindeki ve miyeloperoksidaz aktivitesindeki gruplar arası farklılıkları analiz etmek için tek yönlü varyans analizi (ANOVA) kullanıldı. Daha sonra; post-hoc karşılaştırma yapıldı. Bulgular: Öncelikle; şiddetli travma grubunda lipid peroksidasyon seviyesi ve miyeloperoksidaz aktivitesi önemli ölçüde yüksek bulundu (p<0.05). İkincil olarak; metilprednizolon; orta travma grubunda lipid peroksidasyon seviyesini anlamlı ölçüde düşürüldü (p<0.05); buna karşın şiddetli travma grubunda eritropoietin daha üstündü (p<0.05). Son olarak; eritropoietin her iki travma grubunda da metilprednizolona göre daha etkin bir şekilde miyeloperoksidaz aktivitesini azalttı (p<0.05). Sonuç:Eritropoietin; akciğer dokusunu polimorfonükleer lökosit infiltrasyonuna ve oksidatif hasara karşı etkili bir şekilde korumaktadır. Uygun donör akciğeri ve organ alıcılarında daha iyi sağkalım sağlamak için gerekli klinik çalışmalara yeterli veri transferi yapabilmek amacıyla; kafa travması/ ölümü modelinde akciğerin tedavisini daha da açıklığa kavuşturacak ileri çalışmalara ihtiyaç vardır.



Background:
The effects of erythropoietin and methylprednisolone

on pulmonary lipid peroxidation and myeloperoxidase activity in lung injury following experimental head trauma in rats.

Study design:
Seventy-six female Wistar-Albino rats; weighing 180-220 gr; were evenly allocated into ten groups. A weight-drop method was used to achieve head trauma. Samples were obtained from the left lung 24-h after the injury. Lung tissue-associated myeloperoxidase activity and lipid peroxidation levels were measured. A one-way analysis of variance (ANOVA) was applied to test the differences in the lipid peroxidation levels and myeloperoxidase activities between groups. Then; post-hoc comparison was performed.


Results:
Firstly; head trauma substantially elevated lipid peroxidation and myeloperoxidase activity in lung tissue in the severe trauma group (p<0.05). Secondly; methylprednisolone significantly decreased lipid peroxidation in trauma-moderate group (p<0.05); whereas in trauma-severe group erythropoietin was superior (p<0.05). Thirdly; erythropoietin was more effective than methylprednisolone in decreasing myeloperoxidase activity in both trauma groups (p<0.05).


Conclusion:
Erythropoietin efficiently protected lung tissue against polymorphonuclear leukocytes infiltration and oxidative damage. Further studies are warranted to better clarify the management of lung injury in brain injury/death model to transfer sufficient data to clinical studies providing

suitable donor lungs and better survival rates in recipients.

Key words:
Brain injury/complications/physiopathology; lipid peroxidation; lung/metabolism/pathology; rats; respiratory distress syndrome; adult/etiology /pathology.




Brain injured patients have an increased risk of


extrcerebral organ failure; mainly pulmonary dysfunction.
[


1]
Respiratory failure is a common finding in the


intensive care unit (ICU) and in the management of
complex cases in the operating room.
[2] Since approximately


one-third of these patients suffer respiratory
problems; the efficient management of respiratory failure
in patients with head trauma in ICU has vital importance
in reducing organ failure.
[3]


Direct pulmonary trauma following central nervous
system injury requires immediate treatment to prevent
further compromise of the patient’s condition.
[4]


Treatment with free radical scavengers and antioxidants
is a rational therapeutic strategy for stroke or central
nervous system trauma.
[5] In the present study; both erythropoietin


and methylprednisolone were used to assess
the probable free radical-scavenging effect and the antiinflammatory
effect against induced head injury.
We have recently showed that experimental head
injury resulted in ultrastructural lung tissue injury.
[6] The


aim of the current study; first; was to determine whether
any alteration in the levels of lipid peroxidation and
myeloperoxidase activity existed following traumatic
brain injury. The second aim was to verify to what
extent erythropoietin and methylprednisolone sodium
succinate decrease lung thiobarbituric acid reactive substances
and the severity of polymorphonuclear granulocyte
infiltration in lung tissue.

MATERIALS AND METHODS


The Institutional Review Board for the care of animal

subjects approved the study. The care and handling of
the animals were in accord with the “Principles of
Laboratory animal care” (NIH publication No. 86-23;
revised 1985).

Experimental groups.
Seventy-six female Wistar-

Albino rats; weighing 180-220 g; were randomly allocated
into 10 experimental groups. Tissue samples were
obtained 24 hours after induced brain trauma in all
groups; except the control group. Impact of 200 g-cm
brain injuries was produced in groups 3; 5; 6; and 9.
Additionally; impact of 300 g-cm brain injuries was
produced in groups 4; 7; 8 and 10.
Group 1 (C): Control group (n=8): Tissue samples
were obtained immediately after thoracotomy and neither
head trauma was inducted nor craniotomy was performed.
Group 2 (S): Sham-operated group (n=8): Scalp was
closed after craniotomy and no trauma was stimulated.
Group 3 (Tm): Trauma-moderate group (n=8).
Group 4 (Ts): Trauma-severe group (n=8).
Group 5 (EPOtm): Erythropoietin (trauma-moderate)
group (n=8): Erythropoietin was administered
intraperitoneally by bolus injections of 1000 IU/rat; at
once post trauma.
Group 6 (MPSStm): Methylprednisolone sodium
succinate (trauma-moderate) group (n=8):
Methylprednisolone sodium succinate was given
intraperitoneally by bolus injections of 30 mg/kg;
directly after achieving injury.
Group 7 (EPOts): Erythropoietin (trauma-severe)
group (n=8): Erythropoietin was administered intraperitoneally
by bolus injections of 1000 IU/rat; instantaneously
post trauma.
Group 8 (MPSSts): Methylprednisolone sodium succinate
(trauma-severe) group (n=8): Methylprednisolone
sodium succinate was given intraperitoneally by bolus
injections of 30 mg/kg; immediately after accomplishing
trauma.

Fig. 1.
Lung tissue lipid peroxide levels in all study groups

expressed as nmol /g-wet tissue; mean ± SD. *: Take note that the
severe trauma group has the highest lipid peroxidation level compared
to that of control groups and the moderate trauma group. In
addition; the methylprednisolone sodium succinate is more effective
in lowering lipid peroxidation level in the moderate trauma
group than the severe trauma group. Moreover; erythropoietin is
more effective in decreasing the level of lipid peroxidation in the
severe trauma group than the moderate trauma group.

C: Control group; EPO: Erythropoietin; EPOtm: Erythropoietin (traumamoderate)

group; EPOts: Erythropoietin (trauma-severe) group; LPO: Lipid
peroxidation; MPSS: Methylprednisolone sodium succinate; MPSStm:
Methylprednisolone (trauma-moderate) group; MPSSts: Methylprednisolone
(trauma-severe) group. *: Significant results; S: Sham-operated group;
SD; Standard deviation; TBI: Traumatic brain injury; Tm: Trauma-moderate
group; Ts: Trauma-severe group; Vm: Vehicle-moderate group; Vs:
Vehicle-severe group.
90
*
*
*
80
70
60
50
40
30
20
N= 8
C
S Ts MPSStm Vs
Groups
MPSSts
Tm EPOtm EPOts Vm
8 8 8 8 8 7 8 6 6
LPO activity (nmol/g wet tissue)

Y›ld›r›m ve ark. Deneysel kafa travmas› sonras› geliflen akci¤er hasar›nda; eritropoetin ve metilprednizolonun etkisi


Group 9 (Vm): Vehicle-moderate group (n=6):

Saline (0.9%) was given intraperitoneally by bolus
injections of 0.1 ml/rat; directly after injury.
Group 10 (Vs): Vehicle-severe group (n=6): Saline
(0.9%) was administered intraperitoneally by bolus
injections of 0.1 ml/rat; immediately following injury.

Surgical procedure.
The surgical procedure was performed

under general anaesthesia induced by intramuscular
xylasine (Bayer; Istanbul; Turkey) (10 mg/kg) and
ketamine hydrochloride (Parke Davis; Istanbul; Turkey)
(60 mg/kg) injections. Rats were placed in prone position.
Following midline longitudinal incision; scalp was
dissected over cranium and retracted laterally. Coronal
and sagittal sinuses were observed. Right frontoparietal
craniectomies were carried out laterally to the sagittal
sinus by dental drill system. The dura was exposed and
left intact. Trauma of 200 g-cm and 300 g-cm impacts
were produced by the method of Allen
[7] in different


groups; respectively. Rats were injured by two stainless
steel rods (5 mm diameter; one weighing 200 g and the
other 300 g). Weight dropped vertically through a calibrated
tube from a height of 10 cm onto the exposed
dura. Scalp was sutured with silk sutures. Body temperature
was continuously monitored during the whole
procedure with a rectal thermometer and maintained at
37 °C using a heating pad and an overhead lamp. Rats
were neither intubated nor ventilated between brain
damage and lung sampling. After returning to the cages;
the rats were allowed food and water ad libitum.

Obtaining samples from lung parenchyma.
Twentyfour

hours after traumatic brain injury; animals in all
groups; except the control group; were re-anaesthetized
with the combination of ketamine and xylasine. Rats
were placed supine on the operating table. Midline sternotomy
and left thoracotomy were performed. The systemic
circulation was perfused with 0.9% NaCl. Then;
rats were killed with decapitation under general anaesthesia.
Samples for lipid peroxidation level and
myeloperoxidase activity were simultaneously obtained
from the left pulmonary lobes. Lung samples were collected
in randomly numbered containers and given to
blinded observers. After evaluating the numbered tissues;
results were collected in appropriate group lists.

Lipid peroxidation assay.
The samples were thoroughly

cleansed of blood and were immediately frozen and
stored in a -70 °C freezer for assays of malondialdehyde.
The levels of lipid peroxidation were measured as
thiobarbituric acid-reactive material. The level of lipid
peroxidation in the lung parenchyma was determined
using the method of Mihara and Uchiyama.
[8] Tissues


were homogenized in 10 volumes (w/v) of cold phosphate
buffer (pH 7.4). Half a millilitre of homogenate
was mixed with 3 ml 1% H
3PO4. After the addition of


1 ml 0.67% thiobarbituric acid; the mixture was heated
in boiling water for 45 minutes. The colour was extracted
into n-butanol; and the absorption at 532 nm was
measured. Using tetramethoxypropane as the standard;
tissue lipid peroxidation levels were calculated as
nanomole per gram of wet tissue.

Determination of lung tissue-associated myeloperoxidase

activity.
Lung tissue-associated myeloperoxidase


activity was measured by the modified method of
Suzuki.
[9] Frozen tissue samples were weighed and


homogenized in 1:10 (w/v) ice-cold 10 mM TRIS

Table 1. Lung tissue lipid peroxide levels in each group following graded traumatic brain injury


Groups n Mean±SD
p-value

(nmol/g-wet tissue)
Control group (C) 8 40.312±10.814 –
Sham-operated group (S) 8 40.237±10.622 –
Trauma-moderate group (Tm) 8 52.605±10.088 NS
Ts* 8 61.753±12.327 <0.05
Erythropoietin (trauma-moderate) group (EPOtm) 8 39.310±6.308 NS
MPSStm** 8 35.236±3278 <0.05
EPOts*** 8 44.600±3.428 <0.05
Methylprednisolone (trauma-severe) group (MPSSts) 8 50.531±14.005 NS
Vehicle-moderate group (Vm) 6 52.985±9.808 –
Vehicle-severe group (Vs) 6 62.325±9.515 –

Total
76 47.519±12.817 –


SD: Standard deviation; NS: Non-significant. One-way analysis of variance (ANOVA) was applied to test for differences in lipid peroxidation levels between

groups. Then; post-hoc comparison was performed. The differences were considered significant at a
p value <.05. Ts*: Severe trauma group has the highest lipid


peroxidation level compared to that of control groups and the moderate trauma group. MPSStm**: Methylprednisolone sodium succinate is more effective in lowering
lipid peroxidation level in the moderate trauma group than the severe trauma group. EPOts***: Erythropoietin is more effective in decreasing lipid peroxidation
level in the severe trauma group than the moderate trauma group. EPO: Erythropoietin; EPOts: Erythropoietin (trauma-severe) group; MPSS:
Methylprednisolone sodium succinate; MPSStm: Methylprednisolone (trauma-moderate) group; Ts: Trauma-severe group;

124
Turkish J Thorac Cardiovasc Surg 2006;14(2):122-127


Y›ld›r›m et al. Effects of erythropoietin and methylprednisolone on lung damage after experimental head injury


Türk Gö¤üs Kalp Damar Cer Derg 2006;14(2):122-127
125


Y›ld›r›m ve ark. Deneysel kafa travmas› sonras› geliflen akci¤er hasar›nda; eritropoetin ve metilprednizolonun etkisi


buffer (pH: 7.4) by the use of a dounce homogenizer.

The homogenate (1 ml) was centrifuged at 10000xg for
five times; and the pellet was re-suspended in equal volumes
(1 mL) of 50 mM phosphate buffer (pH: 6.0) containing
0.5% Hexadecyltrimethyl ammonium bromide
(HETAB) and 5 mM EDTA. The resulting suspension
was centrifuged at 5000xg for 2 min and the supernatant
was used for the activity measurement.
Myeloperoxidase activity was measured in a final
volume of 1 ml containing 80 mM phosphate buffer
(pH: 5.4); 0.5% HETAB; 1.6 mM synthetic substrate
tetramethylbenzidine (TMB) initially dissolved in
dimethylformamide; 2 mM H
2O2 and the sample. The


reaction was started at 37 °C by the addition of H
2O2.


Recording the increase of absorbance at 655 nm followed
the initial rate of myeloperoxidase-catalyzed
TMB oxidation. Myeloperoxidase activity was
expressed as the amount of the enzyme producing one
absorbance change per minute under assay conditions.
Tissue-associated myeloperoxidase activity was calculated
as units per gram of wet tissue.

Statistical method.
All the data collected from the

experiment were coded; recorded; and analyzed by
using SPSS 11.5 statistical software package for
Windows. The one-way analysis of variance (ANOVA)
was used to compare lipid peroxidation levels and the
activity of myeloperoxidase. Tukey’s honestly significant
difference (Tukey-HSD) test was applied to determine
the statistically significant differences between
the groups; as post-hoc. The differences were considered
significant at a p value <0.05.

RESULTS


The results below were recorded:

Lipid peroxide levels are shown in Fig. 1 and Table 1:
Only severe trauma significantly increased lipid peroxides
levels (p<0.05); compared to control and sham
groups Additionally; methylprednisolone sodium succinate
caused significant decline in lipid peroxidation level
in the moderate trauma group similar to the moderate
trauma vehicle and the erythropoietin moderate trauma
groups (p<0.05). Moreover; erythropoietin caused significant
decreases in lipid peroxide levels in severe trauma
group compared to methylprednisolone severe trauma
and severe trauma vehicle groups (p<0.05).
Lung tissue-associated myeloperoxidase activities
are shown in Fig. 2 and Table 2:
Only severe trauma caused significant increases in
myeloperoxidase activities (p<0.05). compared to the
control and sham groups. Additionally; erythropoietin
caused a significant decline in myeloperoxidase activities
in both moderate and severe trauma groups. similar to the
methylprednisolone moderate trauma; methylprednisolone
severe trauma and the vehicle groups (p<0.05).

DISCUSSION


Respiratory failure is a common finding in the intensive

care unit and in the management of complex cases in the
operating room.
[2] The development of lung injury is a


critical independent factor affecting mortality in patients
suffering traumatic brain injury and is associated with a
worse long-term neurologic outcome in survivors.
[10]


As approximately one-third of these paitients suffer
respiratory problems; the efficient management of respiratory
failure in patients with head trauma in ICU has
vital importance
[11] in reducing organ failure[3] and providing


higher graft survival rates under conditions of
donor shortage.
[12]


Blunt traumatic brain injury represents one of the
most important causes of death and disability in modern

Fig. 2.
Lung tissue myeloperoxidase activities in all study groups

expressed as IU/g-wet tissue; mean±SD. *Take note that